Lorence H. Kim Moderna, Inc. (MRNA) insider trading activity

Lorence H. Kim is Chief Financial Officer of Moderna, Inc.. Currently has a direct ownership of 1.2 Million shares of MRNA, which is worth approximately $44.3 Million. The most recent transaction as insider was on Jun 02, 2020, when has been sold 241,000 shares (Common Stock) at a price of $58.3 per share, resulting in proceeds of $14,050,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.2M

0% 3M change

0% 12M change

Total Value Held $44.3 Million

Lorence H. Kim Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 02 2020	SELL Open market or private sale	$14,050,300 $58.3 p/Share	241,000 Reduced 16.7%	1,202,510 Common Stock
Jun 02 2020	BUY Exercise of conversion of derivative security	$4,219,910 $17.51 p/Share	241,000 Added 14.31%	1,443,510 Common Stock
May 27 2020	SELL Open market or private sale	$12,322,330 $51.13 p/Share	241,000 Reduced 16.7%	1,202,510 Common Stock
May 27 2020	BUY Exercise of conversion of derivative security	$3,186,020 $13.22 p/Share	241,000 Added 14.31%	1,443,510 Common Stock
May 18 2020	SELL Open market or private sale	$19,795,740 $82.14 p/Share	241,000 Reduced 16.7%	1,202,510 Common Stock
May 18 2020	BUY Exercise of conversion of derivative security	$3,186,020 $13.22 p/Share	241,000 Added 14.31%	1,443,510 Common Stock
May 15 2020	SELL Open market or private sale	$1,307,400 $65.37 p/Share	20,000 Reduced 1.64%	1,202,510 Common Stock
May 12 2020	SELL Open market or private sale	$15,665,000 $65.0 p/Share	241,000 Reduced 16.47%	1,222,510 Common Stock
May 12 2020	BUY Exercise of conversion of derivative security	$2,785,960 $11.56 p/Share	241,000 Added 14.14%	1,463,510 Common Stock
Apr 15 2020	SELL Open market or private sale	$730,000 $36.5 p/Share	20,000 Reduced 1.61%	1,222,510 Common Stock
Mar 16 2020	SELL Open market or private sale	$523,400 $26.17 p/Share	20,000 Reduced 1.58%	1,242,510 Common Stock
Mar 04 2020	SELL Open market or private sale	$554,200 $27.71 p/Share	20,000 Reduced 1.56%	1,262,510 Common Stock
Feb 26 2020	SELL Open market or private sale	$536,058 $28.74 p/Share	18,652 Reduced 1.43%	1,282,510 Common Stock
Feb 25 2020	SELL Open market or private sale	$34,873 $25.87 p/Share	1,348 Reduced 0.1%	1,301,162 Common Stock
Feb 07 2020	SELL Open market or private sale	$767,783 $23.06 p/Share	33,295 Reduced 2.49%	1,302,510 Common Stock
Jan 28 2020	SELL Open market or private sale	$21,033 $23.37 p/Share	900 Reduced 0.07%	1,335,805 Common Stock
Jan 27 2020	SELL Open market or private sale	$547,753 $23.01 p/Share	23,805 Reduced 1.75%	1,336,705 Common Stock
Jan 22 2020	SELL Open market or private sale	$46,080 $23.04 p/Share	2,000 Reduced 0.15%	1,360,510 Common Stock
Dec 06 2019	SELL Open market or private sale	$4,823,117 $20.22 p/Share	238,532 Reduced 14.9%	1,362,510 Common Stock
Dec 06 2019	BUY Exercise of conversion of derivative security	$9,467,877 $20.64 p/Share	458,715 Added 22.27%	1,601,042 Common Stock
Sep 23 2019	SELL Bona fide gift	-	5,000 Reduced 0.44%	1,142,327 Common Stock
Dec 11 2018	BUY Conversion of derivative security	-	458 Added 0.04%	1,147,327 Common Stock

Also insider at

COWN

COWEN INC. Financial Services

RVMD

Revolution Medicines, Inc. Healthcare

ABC

AMERISOURCEBERGEN CORP Healthcare

Director

LHK

Lorence H. Kim

Chief Financial Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account